Mundi Ventures closes a massive €750M fund to support Series B and C rounds for European deeptech startups in quantum and climate sectors.
What This Fund Targets
Mundi Ventures has closed a €750M deeptech fund aimed at Series B and C rounds for European startups. That stage matters: early product-market fit is often already proven, and capital is needed to scale manufacturing, talent, and go-to-market across borders. The focus on quantum and climate puts capital where capital intensity and long development cycles are normal, not exceptional.
Series B and C are where many European deeptech companies stall. Research grants and seed rounds can fund a lab prototype; commercial scale needs different money—working capital, compliance, supply chains, and multi-year sales cycles. A fund sized for those rounds can back companies that already have technical traction but lack the balance sheet to industrialize.
Why Quantum and Climate Need Later-Stage Capital
Quantum and climate startups share hard constraints. Hardware, materials, and infrastructure drive high fixed costs. Regulatory and certification paths can stretch timelines. Customers—enterprises, utilities, governments—buy slowly and demand proof at production quality, not demo quality. Later-stage funding is less about proving the science and more about de-risking delivery: repeatable manufacturing, reliability data, and contracts that survive audit.
Climate tech often collides with physical markets: energy, transport, buildings, industrial process. Quantum often collides with specialized hardware and scarce expertise. Both reward patient capital that can sit through multi-year product cycles without forcing a premature pivot into software-only models that do not match the technology.
What Founders Should Prepare For
Teams raising at Series B or C in these sectors should treat diligence as an operations review, not only a tech review. Investors will scrutinize unit economics under realistic deployment assumptions, supply and talent bottlenecks, and how revenue grows when sales are multi-stakeholder. A clear path from pilot to production—milestones, cost curves, and customer references—matters more than a broader narrative about “disruption.”
- Document manufacturing or deployment readiness with measurable gates, not slideware.
- Separate research risk from commercial risk so capital can be staged against each.
- Plan for cross-border hiring, IP, and regulatory work early; Europe’s market is fragmented by design.
- Show how the next round of capital converts into capacity, not just runway.
What This Means for the European Deeptech Stack
A €750M vehicle focused on European scaling improves the odds that strong B and C companies stay and grow in the region instead of relocating solely for capital. It does not remove the need for earlier-stage ecosystems, public R&D, or corporate partnerships. It does fill a gap where many deeptech firms are past the lab but not yet cash-flow independent.
For operators, corporates, and earlier investors, the signal is practical: more capacity exists to underwrite capital-heavy scaling in quantum and climate. Founders still win by matching technical depth with commercial discipline—clear buyers, defensible IP, and a scaling plan that can absorb large checks without outrunning execution.